Vodianyk Arkadii, Poniatovskyi Vadym, Shyrobokov Volodymyr
Bogomolets National Medical University, av. Beresteiskyi, 34, postal code, Kyiv, 03055, Ukraine.
BMC Res Notes. 2025 Jul 1;18(1):267. doi: 10.1186/s13104-025-07319-8.
To determine the intensity of biofilm formation on different types of central venous catheters in vitro by clinical isolates of bloodstream infection pathogens in Ukraine.
Four clinical strains of Klebsiella pneumonia, four clinical strains of Staphylococcus aureus and four clinical strains of Pseudomonas aeruginosa were isolated from patients from Ukrainian tertial level children`s hospitals during 2023 with bloodstream infections including central line associated blood stream infections. Capacity to form biofilms was assessed using microtiter plate assay and ability to form biofilms in vitro was evaluated on three types of catheters: 1st catheter- surface from medical polyvinyl chloride; 2nd- surface from long-chain polymer based on methacrylate, polyethylene glycol and antiseptic polymeric biguanide; 3rd- silicon surface impregnated with an antimicrobial combination of chlorhexidine acetate and chlorhexidine. Scanning electron microscopy was conducted to assess biofilm formation on the surface of catheters.
Clinical isolates of K pneumonia had similar intensity of biofilm formation on different types of catheters: 1st catheter type- intensity of biofilm formation 0.30-0.34 OD; 2nd catheter type- 0.28-0.37 OD; 3rd catheter type- 0.32-0.37. Clinical isolates of S. aureus form biofilms on all types of catheters by biofilm formation on first type of catheter was lower compared to third type: 1st catheter type- 0.26-0.38 OD; 2nd catheter type- 0.3-0.4 OD; 3rd catheter type- 0.31-0.4 OD (p < 0.05 comparing with 1st catheter). Clinical isolates of P. aeruginosa had the highest ability to form biofilms on catheters. The ability to form biofilms was the most prominent of 3rd types of catheters: 1st catheter type- intensity of biofilm formation 0.38-0.66 OD; 2nd catheter type- 0.44-0.6 OD; 3rd catheter type- 0.54-0.91 OD (p < 0.05 comparing with 1st and 2nd catheter).
P.aeruginosa clinical strains form stronger biofilms compared to other bacteria on all types of catheters. All clinical isolates were able to form biofilm on catheter after 24 h incubation however intensity of biofilm formation by S.aureus and P.aeruginosa on catheters from medical polyvinyl chloride was lower than on other types. There was no difference in biofilm formation on different types of catheters by K.pneumonia strains in vitro.
通过乌克兰血流感染病原体的临床分离株,在体外确定不同类型中心静脉导管上生物膜形成的强度。
2023年期间,从乌克兰三级儿童医院的血流感染(包括中心静脉导管相关血流感染)患者中分离出4株肺炎克雷伯菌临床菌株、4株金黄色葡萄球菌临床菌株和4株铜绿假单胞菌临床菌株。使用微量滴定板法评估形成生物膜的能力,并在三种类型的导管上评估体外形成生物膜的能力:第一种导管——医用聚氯乙烯表面;第二种——基于甲基丙烯酸酯、聚乙二醇和抗菌聚合物双胍的长链聚合物表面;第三种——浸渍有醋酸氯己定和氯己定抗菌组合的硅表面。进行扫描电子显微镜检查以评估导管表面的生物膜形成情况。
肺炎克雷伯菌的临床分离株在不同类型导管上形成生物膜的强度相似:第一种导管类型——生物膜形成强度为0.30 - 0.34 OD;第二种导管类型——0.28 - 0.37 OD;第三种导管类型——0.32 - 0.37。金黄色葡萄球菌的临床分离株在所有类型导管上均能形成生物膜,但第一种导管上的生物膜形成强度低于第三种:第一种导管类型——0.26 - 0.38 OD;第二种导管类型——0.3 - 0.4 OD;第三种导管类型——0.31 - 0.4 OD(与第一种导管相比,p < 0.05)。铜绿假单胞菌的临床分离株在导管上形成生物膜的能力最强。在第三种类型导管上形成生物膜的能力最为突出:第一种导管类型——生物膜形成强度为0.38 - 0.66 OD;第二种导管类型——0.44 - 0.6 OD;第三种导管类型——0.54 - 0.91 OD(与第一种和第二种导管相比,p < 0.05)。
与其他细菌相比,铜绿假单胞菌临床菌株在所有类型导管上形成的生物膜更强。所有临床分离株在孵育24小时后均能在导管上形成生物膜,然而金黄色葡萄球菌和铜绿假单胞菌在医用聚氯乙烯导管上形成生物膜的强度低于其他类型。肺炎克雷伯菌菌株在体外不同类型导管上形成生物膜的情况没有差异。